Profile data is unavailable for this security.
About the company
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
- Revenue in HUF (TTM)901.32bn
- Net income in HUF227.29bn
- Incorporated1923
- Employees11.76k
- LocationRichter Gedeon Vegyeszeti Gyar NyrtGyomroi ut 19-21.BUDAPEST 1103HungaryHUN
- Phone+36 14314000
- Fax+36 12606650
- Websitehttps://www.gedeonrichter.com/hu-hu/
More ▼
Mergers & acquisitions
| Acquired company | RICHTER:BUD since announced | Transaction value |
|---|---|---|
| Granata Bio Inc | 9.81% | -- |
Data delayed at least 15 minutes, as of Feb 16 2026 11:13 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laurus Labs Ltd | 237.09bn | 29.75bn | 1.92tn | 6.17k | 64.74 | -- | 41.64 | 8.12 | 15.61 | 15.61 | 124.44 | -- | -- | -- | -- | 10,899,350.00 | -- | 8.88 | -- | 14.31 | 58.67 | 48.18 | 12.52 | 11.88 | -- | 7.10 | -- | 13.79 | 10.18 | 14.42 | 123.18 | 7.02 | 23.60 | -- |
| Beijing Tong Ren Tang Co Ltd | 836.17bn | 62.59bn | 1.94tn | 17.88k | 31.00 | 3.07 | -- | 2.32 | 0.9871 | 0.9871 | 13.19 | 9.96 | 0.5736 | 0.9376 | 11.40 | 1,011,323.00 | 5.99 | 8.13 | 11.72 | 15.95 | 43.19 | 46.02 | 10.45 | 13.34 | 1.89 | -- | 0.1629 | 33.28 | 4.12 | 6.97 | -8.54 | 9.14 | 2.30 | 5.64 |
| Dottikon ES Holding AG | 176.55bn | 50.33bn | 1.95tn | 841.00 | 38.28 | 4.45 | 32.12 | 11.05 | 8.75 | 8.75 | 30.70 | 75.26 | 0.3175 | 0.6591 | 6.12 | 535,050.40 | 9.05 | 8.05 | 10.52 | 9.25 | 67.57 | 72.37 | 28.51 | 25.67 | 1.71 | -- | 0.1111 | -- | 18.07 | 17.13 | 30.95 | 26.06 | 23.40 | -- |
| Abbott India Ltd | 240.71bn | 53.76bn | 1.98tn | 3.66k | 36.89 | -- | 35.16 | 8.24 | 717.26 | 717.26 | 3,211.47 | -- | -- | -- | -- | 18,650,260.00 | -- | 22.42 | -- | 30.42 | 46.61 | 44.59 | 22.33 | 18.83 | -- | 79.05 | -- | 73.99 | 9.58 | 9.38 | 17.75 | 18.99 | 27.31 | 34.73 |
| Glenmark Pharmaceuticals Ltd | 580.88bn | 37.57bn | 1.99tn | 13.48k | 52.95 | -- | 34.89 | 3.42 | 37.72 | 37.72 | 583.32 | -- | -- | -- | -- | 12,219,440.00 | -- | 1.33 | -- | 1.92 | 71.68 | 60.15 | 6.47 | 1.82 | -- | 16.41 | -- | 39.62 | 12.77 | 4.60 | 155.14 | 6.18 | -4.24 | 0.00 |
| Sumitomo Pharma Co Ltd | 948.37bn | 230.28bn | 2.06tn | 3.83k | 8.92 | 3.40 | 7.46 | 2.17 | 277.11 | 277.11 | 1,141.22 | 727.28 | 0.5438 | 1.95 | 3.99 | 118,318,100.00 | 13.20 | -5.49 | 23.02 | -8.49 | 59.24 | 67.88 | 24.28 | -13.24 | 1.01 | 4.17 | 0.4726 | -- | 26.79 | -3.75 | 107.50 | -10.32 | -0.4856 | -- |
| Rhythm Pharmaceuticals Inc | 55.68bn | -63.15bn | 2.09tn | 283.00 | -- | 43.94 | -- | 37.54 | -3.10 | -3.10 | 2.74 | 4.43 | 0.4006 | 1.03 | 6.66 | 616,021.20 | -44.19 | -52.46 | -57.53 | -61.22 | 89.40 | -- | -110.32 | -354.18 | 4.53 | -27.83 | 0.2693 | -- | 68.06 | -- | -43.26 | -- | -- | -- |
| ALK-Abello A/S | 308.45bn | 55.87bn | 2.18tn | 2.76k | 42.60 | 7.61 | 30.46 | 7.07 | 4.98 | 4.98 | 27.51 | 27.86 | 0.7781 | 1.24 | 6.36 | 2,207,773.00 | 14.09 | 6.01 | 16.80 | 7.60 | 65.94 | 61.95 | 18.11 | 8.44 | 1.35 | 46.81 | 0.0699 | 0.00 | 14.78 | 11.08 | 67.70 | -- | 50.82 | -- |
| Richter Gedeon Vegyeszeti Gyar Nyrt | 901.32bn | 227.29bn | 2.18tn | 11.76k | 9.43 | 1.57 | 7.87 | 2.42 | 1,241.24 | 1,241.24 | 4,922.29 | 7,429.22 | 0.5762 | 1.33 | 3.69 | 76,662,670.00 | 14.52 | 13.55 | 16.23 | 15.35 | 68.65 | 60.79 | 25.20 | 22.34 | 2.83 | -- | 0.0159 | 40.47 | 6.51 | 11.05 | 50.61 | 38.39 | 8.62 | 51.82 |
| Alkem Laboratories Ltd | 489.95bn | 83.28bn | 2.28tn | 18.64k | 27.36 | 4.84 | 23.16 | 4.65 | 197.47 | 197.47 | 1,161.71 | 1,116.21 | 0.7427 | 1.71 | 4.97 | 7,451,003.00 | 12.89 | 12.12 | 17.55 | 17.53 | 63.60 | 60.06 | 17.35 | 14.69 | 1.87 | 18.59 | 0.1457 | 28.96 | 2.34 | 9.21 | 20.59 | 13.95 | 13.22 | 12.47 |
| Aurobindo Pharma Ltd | 1.17tn | 123.00bn | 2.35tn | 9.11k | 19.08 | -- | 12.72 | 2.01 | 60.04 | 60.04 | 571.33 | -- | -- | -- | -- | 36,435,560.00 | -- | 8.62 | -- | 12.13 | 59.35 | 53.55 | 10.50 | 12.38 | -- | 14.24 | -- | 7.25 | 9.39 | 6.55 | 9.86 | 4.15 | 11.98 | -- |
| Beijing Wantai Biolog Pha Ent Co Ltd | 83.02bn | -15.43bn | 2.35tn | 3.79k | -- | 4.20 | -- | 28.28 | -0.2438 | -0.2438 | 1.38 | 9.56 | 0.1234 | 1.11 | 0.8599 | 473,789.40 | -2.30 | 17.63 | -2.69 | 22.63 | 48.33 | 83.87 | -18.67 | 33.20 | 3.82 | -- | 0.0295 | 9.99 | -59.25 | 13.66 | -91.49 | -12.65 | 40.51 | -- |
| 3SBio Inc | 420.00bn | 109.17bn | 2.43tn | 6.27k | 21.62 | 2.99 | 17.83 | 5.78 | 1.08 | 1.08 | 4.16 | 7.83 | 0.3799 | 1.54 | 6.97 | 1,842,772.00 | 10.46 | 7.95 | 15.09 | 10.32 | 85.37 | 83.73 | 27.54 | 22.68 | 2.12 | -- | 0.0899 | -- | 16.53 | 11.36 | 34.93 | 16.51 | 14.65 | -- |
Data as of Feb 16 2026. Currency figures normalised to Richter Gedeon Vegyeszeti Gyar Nyrt's reporting currency: Hungarian Forint HUF
21.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 05 Feb 2026 | 8.49m | 4.56% |
| Orbis Investment Management Ltd.as of 30 Jun 2025 | 5.84m | 3.13% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 5.41m | 2.90% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 3.31m | 1.78% |
| Artemis Investment Management LLPas of 31 Oct 2025 | 2.95m | 1.58% |
| Seafarer Capital Partners LLCas of 31 Dec 2025 | 2.93m | 1.57% |
| Invesco Asset Management Ltd.as of 12 Feb 2026 | 2.88m | 1.55% |
| Templeton Asset Management Ltd.as of 31 Dec 2025 | 2.71m | 1.46% |
| Schroder Investment Management Ltd.as of 31 Dec 2025 | 2.70m | 1.45% |
| Strategic Advisers LLCas of 31 Dec 2025 | 2.49m | 1.34% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
